Identificationof Dual Agonists of fxr and tgr5 as potential leads for the type II Diabetes an in Silico and in Vitro approach

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced